Association between psoriasis and short-term outcomes of acute myocardial infarction: A matched-pair cohort study using a nationwide inpatient database in Japan.
AMI, acute myocardial infarction
CABG, coronary artery bypass graft
ICD-10, International Statistical Classification of Diseases, Tenth Revision
MI, myocardial infarction
OR, odds ratio
PCI, percutaneous coronary intervention
acute myocardial infarction
cardiovascular disease
epidemiology
matched-pair cohort
mortality
nationwide inpatient database
psoriasis
Journal
JAAD international
ISSN: 2666-3287
Titre abrégé: JAAD Int
Pays: United States
ID NLM: 101774762
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
accepted:
13
04
2022
entrez:
27
5
2022
pubmed:
28
5
2022
medline:
28
5
2022
Statut:
epublish
Résumé
Psoriasis is a known risk factor for acute myocardial infarction (AMI). However, the associations between psoriasis and short-term outcomes of AMI remain controversial. To compare the short-term outcomes of AMI patients with and without psoriasis accounting for patient background characteristics and site-specific effects. We identified patients with AMI between July 2010 and March 2020, using a Japanese national inpatient database. We matched patients with and without psoriasis to generate a 1:10 matched-pair cohort matched for sex, hospital, and fiscal year at admission. Multivariable regression analyses with adjustment for background characteristics including age and Killip class at admission were conducted to compare short-term outcomes of AMI. In this study of AMI patients with psoriasis ( Retrospective study design without data on psoriasis severity. The matched-pair cohort analyses with adjustment for patient background characteristics and site-specific effects revealed decreased in-hospital mortality in AMI patients with psoriasis.
Sections du résumé
Background
UNASSIGNED
Psoriasis is a known risk factor for acute myocardial infarction (AMI). However, the associations between psoriasis and short-term outcomes of AMI remain controversial.
Objective
UNASSIGNED
To compare the short-term outcomes of AMI patients with and without psoriasis accounting for patient background characteristics and site-specific effects.
Methods
UNASSIGNED
We identified patients with AMI between July 2010 and March 2020, using a Japanese national inpatient database. We matched patients with and without psoriasis to generate a 1:10 matched-pair cohort matched for sex, hospital, and fiscal year at admission. Multivariable regression analyses with adjustment for background characteristics including age and Killip class at admission were conducted to compare short-term outcomes of AMI.
Results
UNASSIGNED
In this study of AMI patients with psoriasis (
Limitations
UNASSIGNED
Retrospective study design without data on psoriasis severity.
Conclusion
UNASSIGNED
The matched-pair cohort analyses with adjustment for patient background characteristics and site-specific effects revealed decreased in-hospital mortality in AMI patients with psoriasis.
Identifiants
pubmed: 35620322
doi: 10.1016/j.jdin.2022.04.007
pii: S2666-3287(22)00053-0
pmc: PMC9127561
doi:
Types de publication
Journal Article
Langues
eng
Pagination
21-30Informations de copyright
© 2022 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Dr Miyachi has received honoraria from companies that manufacture drugs used for the treatment of psoriasis, including Janssen Pharmaceutical KK, Taiho Pharmaceutical Co Ltd, and AbbVie GK. The other authors have no conflicts of interest to disclose.
Références
N Engl J Med. 2009 Jul 30;361(5):496-509
pubmed: 19641206
JAMA. 2003 Oct 22;290(16):2174-81
pubmed: 14570953
Can J Cardiol. 2020 Jan;36(1):100-111
pubmed: 31606265
N Engl J Med. 1999 May 27;340(21):1640-8
pubmed: 10341277
Lancet. 2015 Sep 5;386(9997):983-94
pubmed: 26025581
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
JAMA. 2006 Oct 11;296(14):1735-41
pubmed: 17032986
Circ Cardiovasc Imaging. 2018 Jun;11(6):e007394
pubmed: 29776990
J Am Acad Dermatol. 2022 Jun;86(6):1266-1274
pubmed: 34116101
J Invest Dermatol. 2020 Jan;140(1):85-93.e2
pubmed: 31326395
Am J Epidemiol. 1999 Jan 15;149(2):195-7
pubmed: 9921965
J Am Coll Cardiol. 2021 Apr 6;77(13):1670-1680
pubmed: 33795041
Circ Rep. 2021 Feb 20;3(3):131-136
pubmed: 33738345
J Dermatol. 2020 Mar;47(3):201-222
pubmed: 31916326
J Am Acad Dermatol. 2021 Jan;84(1):60-69
pubmed: 32798580
Clin Rheumatol. 2017 May;36(5):995-1004
pubmed: 28124758
BMJ Open. 2015 Jan 14;5(1):e006450
pubmed: 25588781
J Eur Acad Dermatol Venereol. 2017 Feb;31(2):205-212
pubmed: 27573025
Circ J. 2020 Jun 25;84(7):1140-1146
pubmed: 32461512
Arch Dermatol. 2009 Jun;145(6):700-3
pubmed: 19528427
BMC Health Serv Res. 2018 Nov 26;18(1):895
pubmed: 30477501
J Cardiol. 2019 Apr;73(4):276-279
pubmed: 30583988
J Intern Med. 2011 Sep;270(3):237-44
pubmed: 21362070
Am J Med. 2018 Mar;131(3):260-268.e1
pubmed: 29037939
Eur Heart J. 2010 Apr;31(8):1000-6
pubmed: 20037179
J Am Acad Dermatol. 2019 Apr;80(4):1029-1072
pubmed: 30772098
Arch Dermatol. 2007 Dec;143(12):1493-9
pubmed: 18086997
Lancet. 2021 Apr 3;397(10281):1301-1315
pubmed: 33812489
Am J Cardiol. 1967 Oct;20(4):457-64
pubmed: 6059183
J Epidemiol. 2017 Oct;27(10):476-482
pubmed: 28142051
N Engl J Med. 2010 Jun 10;362(23):2155-65
pubmed: 20558366
J Dermatol. 2019 Oct;46(10):859-866
pubmed: 31432567
J Am Heart Assoc. 2020 Sep 15;9(18):e016956
pubmed: 32914667
J Invest Dermatol. 2020 Sep;140(9):1784-1793.e2
pubmed: 32088207
Am J Cardiol. 2001 May 1;87(9):1035-8
pubmed: 11348598
J Invest Dermatol. 2019 May;139(5):1054-1062
pubmed: 30508547
BMJ Open. 2021 Jun 3;11(6):e046641
pubmed: 34083341